Jiangsu Hengrui Eyes $2 Billion Hong Kong IPO
Jiangsu Hengrui Pharmaceuticals Co. plans a Hong Kong listing to potentially raise $2 billion. Stay updated on this major pharmaceutical IPO.
Jiangsu Hengrui Pharmaceuticals Co. is planning a Hong Kong listing that could raise at least $2 billion.